{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:03:37Z","timestamp":1763535817062,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41409-021-01213-0","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:55:21Z","timestamp":1611917721000},"page":"1558-1562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-4772","authenticated-orcid":false,"given":"Sachin","family":"Punatar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6767-1544","authenticated-orcid":false,"given":"Siddhesh A.","family":"Kalantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Chichra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingaraj","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Bonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Gokarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-0182","authenticated-orcid":false,"given":"Bhausaheb","family":"Bagal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libin","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-6472","authenticated-orcid":false,"given":"Navin","family":"Khattry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/bmt.2017.207","volume":"53","author":"J Khosla","year":"2018","unstructured":"Khosla J, Yeh AC, Spitzer TR, Dey BR. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. Bone Marrow Transpl. 2018;53:129\u201337. https:\/\/doi.org\/10.1038\/bmt.2017.207.","journal-title":"Bone Marrow Transpl"},{"key":"1213_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452\u201362. https:\/\/doi.org\/10.1182\/blood-2011-02-321315.","journal-title":"Blood"},{"key":"1213_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","volume":"82","author":"C Uderzo","year":"2006","unstructured":"Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006;82:638\u201344.","journal-title":"Transplantation."},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:571\u20135.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1213_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95\u2013100.","journal-title":"Haematologica."},{"key":"1213_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","volume":"41","author":"BS Cho","year":"2008","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S. et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2008;41:813\u201320. https:\/\/doi.org\/10.1038\/sj.bmt.1705976.","journal-title":"Bone Marrow Transpl"},{"key":"1213_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ. et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation . 2010;90:918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/bmt.2008.350","volume":"43","author":"J Thachil","year":"2009","unstructured":"Thachil J. Nitric oxide in transplantation-related thrombotic microangiopathy. Bone Marrow Transpl. 2009;43:513\u20134.","journal-title":"Bone Marrow Transpl"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1182\/blood-2013-07-512707","volume":"122","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Cines DB. TMA: beware of complements. Blood. 2013;122:1997\u20139.","journal-title":"Blood"},{"key":"1213_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/bmt.2016.253","volume":"52","author":"P Dhakal","year":"2017","unstructured":"Dhakal P, Bhatt VR. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy? Bone Marrow Transpl. 2017;52:352\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/j.bbmt.2014.11.348","volume":"21","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin B, Fukuda T, Vinks A, Mizuno K, Goebel J, et al. Eculizumab treatment improves survival in patients with high-risk hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TMA). Biol Blood Marrow Transpl. 2015;21:S225\u2013S226.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40959-015-0008-5","volume":"1","author":"O Pasvolsky","year":"2015","unstructured":"Pasvolsky O, Leader A, Iakobishvili Z, Wasserstrum Y, Kornowski R, Raanani P. Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardio Oncol. 2015;1:5 https:\/\/doi.org\/10.1186\/s40959-015-0008-5.","journal-title":"Cardio Oncol"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1172\/JCI86249","volume":"126","author":"C Guignabert","year":"2016","unstructured":"Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R. et al. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. J Clin Invest. 2016;126:3207\u201318. https:\/\/doi.org\/10.1172\/JCI86249.","journal-title":"J Clin Invest"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01213-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-021-01213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:37Z","timestamp":1684617517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01213-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}